Nasha Fitter co-founded the FOXG1 Research Foundation shortly after her daughter Amara was diagnosed. She is dedicated to finding a cure for every child in the world who has FOXG1 syndrome.

Nasha is the Vice President of Rare and Neurological Diseases for Invitae, formerly consumer health-tech company Ciitizen. Nasha is also on the public board of the ACMG Foundation for Genetic and Genomic Medicine.

Formerly, Nasha was the founder and CEO of tech startup Schoolie, as well as a Director at Microsoft Corp. Nasha has an MBA from the Harvard Business School.

Nicole Johnson is the co-founder of the FOXG1 Research Foundation and mother to ten-year-old Josie, who has a severe mutation of the FOXG1 gene. With more than two decades of experience in media and communications, Nicole serves as Executive Director overseeing every vertical across the organization.

Nicole was a co-founder and Director of Communications for streaming music service, Qello Concerts, sold to Stingray in 2018. Prior, Nicole was a producer for CNN and NBC, and worked in Corporate Communications for several Fortune 500 companies.

Ryan Phillips joined the Foundation in 2020 after receiving his son Crosby's diagnosis. He is dedicated to further our strategic research efforts and empower board decisions with financial analysis to support research goals.

Ryan is an Investment Officer at CalSTRS and was formerly Assistant Vice President at State Street. He has a decade of experience in the finance field where he has worked for large institutions in investment banking and management.

Magdalena joined the Foundation’s Board of Directors in August of 2019 just a few months after her son Diego was diagnosed. Magdalena and her family live in Chile.

Magdalena has over 15 years of experience in different executive human resources roles for global companies leading geographically diverse and multicultural teams.

Elli Brimble leads the Foundation’s clinical research and natural history work. Elli is currently Director of Rare Diseases at Invitae, formerly Ciitizen. Elli was a genetic counselor in Child Neurology at Stanford Children’s Health. She also co-directed Stanford’s Neurogenomics program where she worked on the creation of Natural History Studies for rare, neurological disorders.

Dr. Behesti is a developmental neurobiologist from the Rockefeller University (New York). She has developed models to study the dynamics of human brain development and has been studying the cellular and molecular functions of autism-risk genes in the cerebellum. Dr. Behesti oversees the Foundation’s research portfolio. She works closely with the CEO and Scientific Advisory Board on the foundation’s scientific strategy and implementation of research projects.

Bram joined the foundation in 2021 and is father of two-year-old Benjamin, who was diagnosed with a FOXG1 mutation.

Bram has more than 15 years of financial services industry experience and has worked at financial institutions ABN AMRO, Royal Bank of Scotland, Barclays, and currently works at corporate and investment bank, Natixis where he is a Director in the structural balance sheet risk team.

Previously, Bram was head of asset and liability management for Asia Pacific at Natixis Hong Kong. Bram has a Masters of Science in Financial Management with a degree from Tilburg University.